Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CSI (Cardiac Science Inc) sees "best ever" quarter 1, resolves Philips row

This article was originally published in Clinica

Executive Summary

Shares in Cardiac Science Inc (CSI), the Bothell, Washington-based heart diagnostic and therapeutic device developer, rallied to a 52-week high after the company reported a 43% growth in defibrillator sales during the first quarter of 2007. Said to be its "best ever performance yet", the results were boosted by significant increases in both domestic (+59%) and international (+29%) sales of its automated external defibrillator (AED). However, this was offset by a 16% decline in revenue from cardiac monitoring sales, which the company said has been flat for the last three quarters. Total revenue for the quarter was $41.7m, up 7% from the prior year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048264

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel